Raquel Fortunato, GenIbet CEO

Re­ci­phar­m's glob­al deal spree con­tin­ues with ac­qui­si­tion of Por­tuguese CD­MO

Fol­low­ing a mon­ster 2021, in which CD­MO Re­ci­pharm ex­pand­ed its foot­print across the world in places with a small­er man­u­fac­tur­ing pres­ence, it’s ex­pand­ing its foot­print …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.